Income Statement AS ONE Corporation

Stocks

7476

JP3131300000

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-06-11 am EDT			5-day change	1st Jan Change
2,174.50 ^JPY	+0.37%		+3.30%	-9.55%

May. 13	AS ONE Corporation Reports Sales Results for the Month of April 2026	CI
May. 13	AS ONE Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2027	CI

d9adbd33e8b0c067ec14c2fb15d47c.3YxOuGAaOD8hwQJKSs5hSFYfADHWxDIXW9mJSyOD43A.n-sW_StqdkgMr1IZK_s0DxV3RwHgvnxfPPT6BVfH1QjoxxHQCH0AUWKvUw

Published financial data: AS ONE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	81.61B	86.95B	91.42B	95.54B	104B
Total Revenues	81.61B	86.95B	91.42B	95.54B	104B
Cost of Goods Sold, Total	55.68B	61.41B	62.97B	66.29B	72.44B
Gross Profit	25.93B	25.54B	28.45B	29.25B	31.32B
Selling General & Admin Expenses, Total	16.02B	16.18B	17.06B	18.8B	19.72B
Provision for Bad Debts	12M	21M	-6M	8M	-
Other Operating Expenses, Total	16.04B	16.2B	17.05B	18.81B	19.72B
Operating Income	9.89B	9.34B	11.4B	10.44B	11.59B
Interest Expense, Total	-10M	-2M	-2M	-4M	-8M
Interest And Investment Income	112M	125M	150M	192M	211M
Net Interest Expenses	102M	123M	148M	188M	203M
Currency Exchange Gains (Loss)	-31M	-144M	-119M	-90M	-16M
Other Non Operating Income (Expenses)	283M	247M	212M	291M	288M
EBT, Excl. Unusual Items	10.25B	9.57B	11.64B	10.82B	12.07B
Gain (Loss) On Sale Of Investments	-428M	219M	30M	-	-243M
Gain (Loss) On Sale Of Assets	-52M	674M	-	-	-
Asset Writedown	-826M	-8M	-	-	-
EBT, Incl. Unusual Items	8.94B	10.45B	11.67B	10.82B	11.83B
Income Tax Expense	2.95B	3.25B	3.56B	3.32B	3.6B
Earnings From Continuing Operations	5.99B	7.2B	8.11B	7.5B	8.23B
Net Income to Company	5.99B	7.2B	8.11B	7.5B	8.23B
Net Income - (IS)	5.99B	7.2B	8.11B	7.5B	8.23B
Net Income to Common Incl Extra Items	5.99B	7.2B	8.11B	7.5B	8.23B
Net Income to Common Excl. Extra Items	5.99B	7.2B	8.11B	7.5B	8.23B
Per Share Items
Net EPS - Basic	80.13	96.33	109.44	103.65	114.88
Basic EPS - Continuing Operations	80.13	96.33	109.44	103.65	114.88
Basic Weighted Average Shares Outstanding	74.73M	74.77M	74.12M	72.36M	71.63M
Net EPS - Diluted	80.03	96.2	109.3	103.5	114.72
Diluted EPS - Continuing Operations	80.03	96.2	109.3	103.5	114.72
Diluted Weighted Average Shares Outstanding	74.83M	74.87M	74.22M	72.46M	71.74M
Normalized Basic EPS	85.7	79.98	98.12	93.5	105.3
Normalized Diluted EPS	85.58	79.87	97.99	93.37	105.15
Dividend Per Share	40.25	48.5	55.5	56	62
Payout Ratio	42.82	49.15	46.59	54.64	51.45
Supplemental Items
EBITDA	11.59B	11.07B	13.04B	12.26B	13.4B
EBITA	9.98B	9.34B	11.4B	10.44B	11.59B
EBIT	9.89B	9.34B	11.4B	10.44B	11.59B
EBITDAR	-	-	-	14.25B	15.07B
Effective Tax Rate - (Ratio)	33.02	31.1	30.47	30.72	30.42
Normalized Net Income	6.4B	5.98B	7.27B	6.77B	7.54B
Non-Cash Pension Expense	7.07M	19.63M	79.05M	-62.13M	-238M
Supplemental Operating Expense Items
Selling and Marketing Expenses	4.09B	4.6B	4.66B	4.76B	5.18B
Research And Development Expense From Footnotes	28M	17M	25M	17M	12M
Net Rental Expense, Total	-	-	-	1.99B	1.68B
Imputed Operating Lease Interest Expense	-	-	-	13.03M	19.88M
Imputed Operating Lease Depreciation	-	-	-	1.98B	1.66B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	14.35B	18.72B	17.61B	13.18B	22.57B
Short Term Investments	3.5B	500M	1B	700M	-
Total Cash And Short Term Investments	17.85B	19.22B	18.61B	13.88B	22.57B
Accounts Receivable, Total	31.17B	31.81B	32.33B	35.65B	34.62B
Total Receivables	31.17B	31.81B	32.33B	35.65B	34.62B
Inventory	8.97B	8.17B	11.01B	10.83B	11.72B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	728M	709M	714M	862M	1.04B
Total Current Assets	58.72B	59.9B	62.66B	61.23B	69.96B
Net Property Plant And Equipment	8.94B	8.09B	7.7B	8.11B	8.17B
Long-term Investments	25.01B	26.52B	25.47B	24.76B	19.77B
Goodwill	-	-	-	-	-
Other Intangibles, Total	1.52B	1.55B	1.56B	1.63B	1.59B
Deferred Tax Assets Long-Term	41M	33M	86M	102M	660M
Other Long-Term Assets, Total	3M	2M	2M	2M	1M
Total Assets	94.22B	96.1B	97.48B	95.83B	100B
Liabilities
Accounts Payable, Total	19.07B	19.49B	19.69B	19.94B	18.32B
Accrued Expenses, Total	913M	864M	879M	964M	1.24B
Short-term Borrowings	1.6B	1.6B	2.75B	1.29B	2.44B
Current Income Taxes Payable	2.07B	1.53B	2.22B	1.61B	2.22B
Other Current Liabilities	1.95B	2.24B	1.77B	2.3B	2.28B
Total Current Liabilities	25.6B	25.72B	27.3B	26.1B	26.49B
Long-Term Debt	3.1B	1.5B	3.44B	2.31B	4.75B
Pension & Other Post Retirement Benefits	14M	13M	122M	83M	24M
Deferred Tax Liability Non Current	1.08B	1.02B	906M	533M	-
Other Non Current Liabilities	1.67B	1.7B	1.74B	2.14B	2.16B
Total Liabilities	31.46B	29.95B	33.51B	31.17B	33.43B
Common Stock, Total	5.08B	5.08B	5.08B	5.08B	5.08B
Additional Paid In Capital	4.81B	4.83B	4.34B	4.34B	4.35B
Retained Earnings	52.42B	56.07B	58.29B	60.64B	64.64B
Treasury Stock	-6.16B	-6.11B	-9.99B	-10.93B	-10.84B
Comprehensive Income and Other	6.61B	6.28B	6.26B	5.54B	3.49B
Total Common Equity	62.76B	66.15B	63.97B	64.66B	66.71B
Minority Interest	-	-	-	-	-
Total Equity	62.76B	66.15B	63.97B	64.66B	66.71B
Total Liabilities And Equity	94.22B	96.1B	97.48B	95.83B	100B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	74.75M	74.77M	72.38M	71.7M	71.65M
ECS Total Common Shares Outstanding	74.75M	74.77M	72.38M	71.61M	71.65M
Book Value / Share	839.63	884.7	883.8	903.01	931.02
Tangible Book Value	61.24B	64.6B	62.4B	63.03B	65.12B
Tangible Book Value Per Share	819.32	863.97	862.19	880.19	908.83
Total Debt	4.7B	3.1B	6.19B	3.6B	7.19B
Net Debt	-13.15B	-16.12B	-12.42B	-10.28B	-15.39B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-47.82M	1.62M	117M	78.6M	-135M
Debt Equivalent Oper. Leases	-	-	-	15.94B	13.41B
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Inventories - Raw Materials, Total	105M	98M	153M	156M	176M
Inventories - Work In Process, Total	-	1M	1M	2M	-
Inventories - Finished Goods, Total	8.87B	8.07B	10.85B	10.67B	11.54B
Inventories - Others	1M	1M	1M	-	-
Full Time Employees	631	648	668	711	731
Accumulated Allowance for Doubtful Accounts (Supple)	14M	23M	9M	10M	7M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	8.94B	10.45B	11.67B	10.82B	11.83B
Depreciation & Amortization - CF	1.61B	1.72B	1.64B	1.82B	1.8B
Amortization of Goodwill and Intangible Assets - (CF)	85M	-	-	-	-
Depreciation & Amortization, Total	1.7B	1.72B	1.64B	1.82B	1.8B
(Gain) Loss From Sale Of Asset	877M	-668M	7M	1M	2M
(Gain) Loss on Sale of Investments - (CF)	428M	-219M	-30M	-	243M
Other Operating Activities, Total	-2.81B	-3.56B	-2.98B	-3.92B	-3.14B
Change In Accounts Receivable	-4.76B	-611M	-456M	-3.06B	1.17B
Change In Inventories	-1.91B	861M	-2.82B	465M	-857M
Change In Accounts Payable	2.07B	806M	-265M	432M	-1.76B
Change in Other Net Operating Assets	847M	52M	204M	-67M	25M
Cash from Operations	5.38B	8.84B	6.97B	6.5B	9.31B
Capital Expenditure	-1.66B	-633M	-570M	-942M	-1.21B
Sale of Property, Plant, and Equipment	-	951M	-	-	6M
Cash Acquisitions	-	-	-	-418M	-
Sale (Purchase) of Intangible assets	-534M	-518M	-583M	-634M	-583M
Investment in Marketable and Equity Securities, Total	295M	795M	1.12B	12M	2.62B
Other Investing Activities, Total	-222M	-4M	-333M	54M	9M
Cash from Investing	-2.12B	591M	-367M	-1.93B	850M
Long-Term Debt Issued, Total	5B	-	5B	-	5B
Total Debt Issued	5B	-	5B	-	5B
Short Term Debt Repaid, Total	-	-	-	-60M	-
Long-Term Debt Repaid, Total	-2.4B	-1.6B	-1.91B	-2.78B	-1.42B
Total Debt Repaid	-2.4B	-1.6B	-1.91B	-2.84B	-1.42B
Issuance of Common Stock	485M	14M	16M	21M	21M
Repurchase of Common Stock	-458M	-3M	-6.57B	-2.08B	-
Common Dividends Paid	-2.56B	-3.54B	-3.78B	-4.1B	-4.23B
Common & Preferred Stock Dividends Paid	-2.56B	-3.54B	-3.78B	-4.1B	-4.23B
Other Financing Activities, Total	-52M	-33M	-36M	-45M	-31M
Cash from Financing	11M	-5.16B	-7.28B	-9.04B	-659M
Foreign Exchange Rate Adjustments	-4M	103M	76M	57M	119M
Miscellaneous Cash Flow Adjustments	-1M	-1M	-	-	1M
Net Change in Cash	3.27B	4.37B	-605M	-4.41B	9.62B
Supplemental Items
Cash Interest Paid	10M	2M	2M	4M	4M
Cash Income Tax Paid (Refund)	2.84B	3.6B	3.01B	3.93B	3.16B
Levered Free Cash Flow	1.88B	6.72B	4.69B	3.73B	6.46B
Unlevered Free Cash Flow	1.89B	6.72B	4.69B	3.73B	6.46B
Change In Net Working Capital	3.8B	-313M	2.93B	3.04B	794M
Net Debt Issued / Repaid	2.6B	-1.6B	3.09B	-2.84B	3.58B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.04	6.14	7.36	6.75	7.4
Return on Total Capital	9.81	8.54	10.22	9.42	10.19
Return On Equity %	10.04	11.17	12.47	11.66	12.53
Return on Common Equity	10.04	11.17	12.47	11.66	12.53
Margin Analysis
Gross Profit Margin %	31.77	29.38	31.12	30.62	30.18
SG&A Margin	19.63	18.61	18.66	19.68	19.01
EBITDA Margin %	14.2	12.73	14.26	12.83	12.91
EBITA Margin %	12.23	10.74	12.47	10.92	11.17
EBIT Margin %	12.12	10.74	12.47	10.92	11.17
Income From Continuing Operations Margin %	7.34	8.28	8.87	7.85	7.93
Net Income Margin %	7.34	8.28	8.87	7.85	7.93
Net Avail. For Common Margin %	7.34	8.28	8.87	7.85	7.93
Normalized Net Income Margin	7.85	6.88	7.96	7.08	7.27
Levered Free Cash Flow Margin	2.31	7.73	5.13	3.9	6.23
Unlevered Free Cash Flow Margin	2.32	7.73	5.13	3.91	6.23
Asset Turnover
Asset Turnover	0.93	0.91	0.94	0.99	1.06
Fixed Assets Turnover	9.17	10.21	11.58	12.09	12.75
Receivables Turnover (Average Receivables)	2.83	2.76	2.85	2.81	2.95
Inventory Turnover (Average Inventory)	6.95	7.16	6.57	6.07	6.43
Short Term Liquidity
Current Ratio	2.29	2.33	2.29	2.35	2.64
Quick Ratio	1.92	1.98	1.87	1.9	2.16
Operating Cash Flow to Current Liabilities	0.21	0.34	0.26	0.25	0.35
Days Sales Outstanding (Average Receivables)	128.79	132.18	128.03	130.21	123.62
Days Outstanding Inventory (Average Inventory)	52.54	50.95	55.58	60.29	56.81
Average Days Payable Outstanding	113.33	116.09	108.64	109.69	95.23
Cash Conversion Cycle (Average Days)	68	67.04	74.97	80.81	85.19
Long Term Solvency
Total Debt/Equity	7.49	4.69	9.67	5.57	10.77
Total Debt / Total Capital	6.97	4.48	8.82	5.28	9.73
LT Debt/Equity	4.94	2.27	5.37	3.58	7.12
Long-Term Debt / Total Capital	4.6	2.17	4.9	3.39	6.43
Total Liabilities / Total Assets	33.39	31.17	34.38	32.53	33.39
EBIT / Interest Expense	989.2	4.67K	5.7K	2.61K	1.45K
EBITDA / Interest Expense	1.16K	5.53K	6.52K	3.06K	1.67K
(EBITDA - Capex) / Interest Expense	993.6	5.22K	6.24K	2.83K	1.52K
Total Debt / EBITDA	0.41	0.28	0.47	0.29	0.54
Net Debt / EBITDA	-1.13	-1.46	-0.95	-0.84	-1.15
Total Debt / (EBITDA - Capex)	0.47	0.3	0.5	0.32	0.59
Net Debt / (EBITDA - Capex)	-1.32	-1.54	-1	-0.91	-1.26
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	15.94	6.55	5.14	4.5	8.6
Gross Profit, 1 Yr. Growth %	18.12	-1.48	11.37	2.81	7.06
EBITDA, 1 Yr. Growth %	21.54	-4.53	17.85	-5.99	9.26
EBITA, 1 Yr. Growth %	15.14	-6.36	21.99	-8.42	11.1
EBIT, 1 Yr. Growth %	15.68	-5.56	21.99	-8.42	11.1
Earnings From Cont. Operations, 1 Yr. Growth %	0.37	20.27	12.64	-7.54	9.72
Net Income, 1 Yr. Growth %	0.37	20.27	12.64	-7.54	9.72
Normalized Net Income, 1 Yr. Growth %	16.14	-6.62	21.62	-6.98	11.49
Diluted EPS Before Extra, 1 Yr. Growth %	0.3	20.21	13.61	-5.31	10.84
Accounts Receivable, 1 Yr. Growth %	18.01	2.03	1.63	10.29	-2.88
Inventory, 1 Yr. Growth %	27.18	-8.95	34.71	-1.6	8.18
Net Property, Plant and Equip., 1 Yr. Growth %	0.74	-9.45	-4.89	5.35	0.73
Total Assets, 1 Yr. Growth %	15.59	2	1.43	-1.69	4.5
Tangible Book Value, 1 Yr. Growth %	12.98	5.49	-3.41	1	3.32
Common Equity, 1 Yr. Growth %	11.1	5.41	-3.31	1.09	3.16
Cash From Operations, 1 Yr. Growth %	-14.75	64.28	-21.17	-6.79	43.33
Capital Expenditures, 1 Yr. Growth %	-54.18	-61.75	-9.95	65.26	28.03
Levered Free Cash Flow, 1 Yr. Growth %	113.12	256.83	-30.29	-20.44	73.22
Unlevered Free Cash Flow, 1 Yr. Growth %	111.14	255.71	-30.28	-20.41	73.23
Dividend Per Share, 1 Yr. Growth %	0.62	20.5	14.43	0.9	10.71
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	10.58	11.15	5.84	4.82	6.53
Gross Profit, 2 Yr. CAGR %	12.14	7.88	4.75	7.01	4.92
EBITDA, 2 Yr. CAGR %	16.67	7.72	6.07	5.26	1.35
EBITA, 2 Yr. CAGR %	14	3.83	6.88	5.69	0.86
EBIT, 2 Yr. CAGR %	14.37	4.52	7.33	5.69	0.86
Earnings From Cont. Operations, 2 Yr. CAGR %	6.66	9.87	16.39	2.05	0.72
Net Income, 2 Yr. CAGR %	6.66	9.87	16.39	2.05	0.72
Normalized Net Income, 2 Yr. CAGR %	14.53	4.14	6.57	6.37	1.84
Diluted EPS Before Extra, 2 Yr. CAGR %	6.61	9.8	16.86	3.72	2.45
Accounts Receivable, 2 Yr. CAGR %	9.9	9.73	1.83	5.87	3.49
Inventory, 2 Yr. CAGR %	9.66	7.61	10.75	15.13	3.17
Net Property, Plant and Equip., 2 Yr. CAGR %	29.27	-4.49	-7.2	0.1	3.02
Total Assets, 2 Yr. CAGR %	9.37	8.58	1.71	-0.14	1.36
Tangible Book Value, 2 Yr. CAGR %	9.32	9.17	0.94	-1.23	2.15
Common Equity, 2 Yr. CAGR %	8.56	8.21	0.96	-1.13	2.12
Cash From Operations, 2 Yr. CAGR %	-3.6	18.34	13.8	-14.28	15.59
Capital Expenditures, 2 Yr. CAGR %	58.35	-58.14	-41.31	21.99	45.46
Levered Free Cash Flow, 2 Yr. CAGR %	-37.09	175.77	57.72	-25.53	17.39
Unlevered Free Cash Flow, 2 Yr. CAGR %	-37.11	174.05	57.48	-25.51	17.42
Dividend Per Share, 2 Yr. CAGR %	6.86	10.11	17.43	7.45	5.69
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.21	9.22	9.11	5.39	6.06
Gross Profit, 3 Yr. CAGR %	12.05	7.4	9.03	4.1	7.03
EBITDA, 3 Yr. CAGR %	15.79	9.13	10.99	1.89	6.57
EBITA, 3 Yr. CAGR %	14.79	6.76	9.56	1.51	7.46
EBIT, 3 Yr. CAGR %	14.46	7.3	10.05	1.8	7.46
Earnings From Cont. Operations, 3 Yr. CAGR %	8.53	11.01	10.79	7.79	4.54
Net Income, 3 Yr. CAGR %	8.53	11.01	10.79	7.79	4.54
Normalized Net Income, 3 Yr. CAGR %	14.4	7	9.67	1.85	8.05
Diluted EPS Before Extra, 3 Yr. CAGR %	8.76	10.96	11.06	8.95	6.04
Accounts Receivable, 3 Yr. CAGR %	7.87	7.21	6.96	4.58	2.87
Inventory, 3 Yr. CAGR %	8.57	3.07	15.98	6.47	12.77
Net Property, Plant and Equip., 3 Yr. CAGR %	19.05	14.81	-4.62	-3.19	0.31
Total Assets, 3 Yr. CAGR %	6.41	6.85	6.14	0.57	1.38
Tangible Book Value, 3 Yr. CAGR %	6.84	8.03	4.8	0.96	0.26
Common Equity, 3 Yr. CAGR %	6.34	7.5	4.23	1	0.28
Cash From Operations, 3 Yr. CAGR %	21.01	15.14	3.36	6.48	1.75
Capital Expenditures, 3 Yr. CAGR %	41.43	-1.38	-45.96	-17.13	23.97
Levered Free Cash Flow, 3 Yr. CAGR %	-19.95	12.19	74.37	25.55	-1.33
Unlevered Free Cash Flow, 3 Yr. CAGR %	-20.04	12.05	73.65	25.44	-1.31
Dividend Per Share, 3 Yr. CAGR %	8.8	11.22	11.54	11.64	8.53
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.78	9.22	8.44	7.44	8.07
Gross Profit, 5 Yr. CAGR %	9.93	8.61	9.07	7.24	7.37
EBITDA, 5 Yr. CAGR %	11.25	9.27	11.8	7.56	7.03
EBITA, 5 Yr. CAGR %	11.29	8.92	11.56	6.33	6
EBIT, 5 Yr. CAGR %	11.1	8.92	11.56	6.65	6.28
Earnings From Cont. Operations, 5 Yr. CAGR %	9.08	11.33	11.61	7.34	6.64
Net Income, 5 Yr. CAGR %	9.08	11.33	11.61	7.34	6.64
Normalized Net Income, 5 Yr. CAGR %	11.13	8.7	11.2	6.74	6.47
Diluted EPS Before Extra, 5 Yr. CAGR %	9.61	11.76	11.93	8.01	7.53
Accounts Receivable, 5 Yr. CAGR %	9.33	8.93	5.41	6.67	5.56
Inventory, 5 Yr. CAGR %	8.88	5.87	9.43	7.73	10.68
Net Property, Plant and Equip., 5 Yr. CAGR %	9.18	8.41	7.76	8.68	-1.64
Total Assets, 5 Yr. CAGR %	6.24	6.25	4.51	4	4.2
Tangible Book Value, 5 Yr. CAGR %	5.18	5.51	4.44	4.23	3.74
Common Equity, 5 Yr. CAGR %	5.24	5.69	4.15	3.96	3.38
Cash From Operations, 5 Yr. CAGR %	0.29	13.32	18.07	2.32	8.09
Capital Expenditures, 5 Yr. CAGR %	46.41	-4.14	-0.52	7.37	-19.7
Levered Free Cash Flow, 5 Yr. CAGR %	-14.69	13.25	4.99	-4.77	48.84
Unlevered Free Cash Flow, 5 Yr. CAGR %	-14.79	13.05	4.86	-4.83	48.49
Dividend Per Share, 5 Yr. CAGR %	9.77	12.02	12.17	9.7	9.16